{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:11:35Z","timestamp":1792033895935,"version":"4.4.0"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T00:00:00Z","timestamp":1269388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>Targeting host factors is a complementary strategy for the development of new antiviral drugs. We screened a library of isoxazolidine and isoxazole sulfonamides and found four compounds that inhibited HIV\u20101 infection in human CD4+ lymphocytic T cells with no toxicity at IC<jats:sub>90<\/jats:sub> concentrations. Structure\u2010activity relationship showed that benzyl sulfonamides and a halo\u2010substituted aromatic ring on the heterocycle scaffold were critical for antiretroviral activity. The size and position of the incorporated halogen had a marked effect on the antiretroviral activity. The sulfonamide derivatives had no significant effect on HIV\u20101 entry, reverse transcription and integration but impaired a step necessary for activation of viral gene expression. This step was Tat\u2010independent, strongly suggesting that the target is a cell factor. A virus partially resistant to the least potent compounds could be selected but could not be propagated in the long term, consistent with the possibility that HIV\u20101 may be less likely to develop resistance against drugs targeting some host factors. Here, we provide evidence that novel synthetic methods can be applied to develop small molecules with antiretroviral activity that target host factors important for HIV\u20101 replication.<\/jats:p>","DOI":"10.1111\/j.1747-0285.2010.00956.x","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T12:32:14Z","timestamp":1275481934000},"page":"461-474","source":"Crossref","is-referenced-by-count":90,"title":["Inhibition of HIV\u20101 Replication by Isoxazolidine and Isoxazole Sulfonamides"],"prefix":"10.1111","volume":"75","author":[{"given":"Belinda","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Vozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. James","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Caddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariberto","family":"Fassati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013552"},{"key":"e_1_2_7_4_2","first-page":"67","article-title":"HIV\u20101 drug resistance mutations: an updated framework for the second decade of HAART","volume":"10","author":"Shafer R.W.","year":"2008","journal-title":"AIDS Rev"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38665.534595.55"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01556-08"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-1-201"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4721-4732.2005"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1319"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1152725"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.032"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2008.10.004"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03196"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2410"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/ol0347388"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1039\/b911098d"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430340252898984"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3626-3635.2001"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2006.00449.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.59.2.284-291.1986"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.66.6.3531-3537.1992"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-11"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/275458a0"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.38.072902.094136"},{"key":"e_1_2_7_25_2","volume-title":"Fields\u2019 Virology","author":"Fields B.N.","year":"2007"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.8.3739-3747.2002"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000207"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.011008.145553"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(01)00330-5"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.11.5670-5678.2004"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1701568"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1993.tb05994.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.20081"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00449.x"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0285.2010.00956.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1747-0285.2010.00956.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T03:11:47Z","timestamp":1697339507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1747-0285.2010.00956.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1747-0285.2010.00956.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1747-0285.2010.00956.x","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,24]]}}}